WOOJUNG BIO (215380) Stock Overview

WOOJUNG BIO, Inc. provides research and laboratory services in Korea. The company offers environmental infection control. It also provides construction solutions, such as preventing clean and infected; hospital negative pressure isolation ward; pharmaceutical company's aseptic production rooms; general and animal laboratory; high-risk pathogen research facility; and HEPA box air conditioning systems. In addition, the company offers tab verification; equipment systems; space sterilizers, including HPV and plasmair; sterilizers other than autoclave, and washer; hospital central supply system; no-touch waste treatment system; wastewater verification treatment; waste verification process; hospital infection control; intensive care unit; space sterilization and validation services, such as managed areas, room numbers, and various patient package services through product selection with counseling; and facility sterilization verification services. Further, it provides equipment maintenance services; various customized services; and guidance and communication services. WOOJUNG BIO, Inc. was founded in 1989 and is based in Suwon, South Korea.